Skip directly to page options Skip directly to A-Z link

Volume 26, Number 11—November 2020

Research Letter

Large Outbreak of Guillain-Barré Syndrome, Peru, 2019

César V. Munayco, Ronnie G. Gavilan, Gladys Ramirez, Manuel Loayza, Maria L. Miraval, Erin Whitehouse, Radhika Gharpure, Jesus Soares, Hans Vasquez Soplopuco, and James SejvarComments to Author 
Author affiliations: Centro Nacional de Epidemiología Prevención y Control de Enfermedades, Lima, Peru (C.V. Munayco, G. Ramirez, M. Loayza); Instituto Nacional de Salud, Lima (R.G. Gavilan, M.L. Miraval, H.V. Soplopuco); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (E. Whitehouse, R. Gharpure, J. Soares, J. Sejvar)

Main Article

Table

General characteristics of persons with Guillain-Barré syndrome, Peru, 2019

Characteristic No. cases Population Cases/100,000 population
Sex
M 401 10,416,496 3.85
F 282 10,882,518 2.59
Age, y
0–11 48 4,321,980 1.11
12–17 45 2,223,271 2.02
18–29 118 4,498,823 2.62
30–59 333 7,870,813 4.23
>60 139 2,384,127 5.83
Area
Junín 132 1,389,850 9.50
Piura 115 1,901,896 6.05
Cajamarca 53 1,543,104 3.43
La Libertad 57 1,956,389 2.91
Lambayeque 31 1,300,720 2.38
Lima 247 10,458,367 2.36
Callao 25 1,067,815 2.34
Huancavelica 10 509,117 1.96
Ancash 13 1,171,756 1.11
Total 683 21,299,014 3.21
Peru, total 709 32,526,084 2.18

Main Article

Page created: August 25, 2020
Page updated: October 19, 2020
Page reviewed: October 19, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external